Compare Hims and Hers Health Inc (HIMS) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs NIO Inc. — how do they compare? Hims and Hers Health Inc trades at $32.37 (market cap $7.57B), while NIO Inc. trades at $4.81 (market cap $12.55B). The key difference: NIO Inc. is the larger of the two by market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| HIMS | NIO | |
|---|---|---|
Market Cap | $7.57B | $12.55B |
Sector | Health | Consumer Cyclical |
52-Week High | $66.18 | $7.89 |
52-Week Low | $14.52 | $4.44 |
Enterprise Value | $7.95B | $11.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
NIO trades at $4.83, down 1.02% on the day, with a bearish technical signal from moving averages. Revenue grew to $87.49B in 2025, but the company posted a net loss of $15.57B, reflecting persistent profitability challenges. Recent news highlights strong Q2 2026 vehicle deliveries, up 49.4% year-over-year, and a Goldman Sachs upgrade to Buy with a $7 price target, suggesting potential upside.
The outlook remains mixed: delivery growth and analyst optimism contrast with deep losses and negative cash flow. Key risks include intense EV competition and reliance on financing. Investors should weigh the growth trajectory against the path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
